-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on WAVE Life Sciences, Lowers Price Target to $21

Benzinga·03/27/2026 14:11:32
Listen to the news
B of A Securities analyst Alec Stranahan maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $38 to $21.